Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures

Luca Giovanella; Luca Ceriani; Antonella Ghelfo; Franco Keller; Andrea Sacchi; Marco Maffioli; Giuseppe Spriano

doi:10.1515/cclm.2006.107

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm.2006.107 ◽

2006 ◽

Vol 44 (5) ◽

Cited By ~ 29

Author(s):

Luca Giovanella ◽

Luca Ceriani ◽

Antonella Ghelfo ◽

Franco Keller ◽

Andrea Sacchi ◽

...

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Imaging Procedures ◽

Cancer Management ◽

Thyroxine Treatment ◽

Recombinant Human Thyrotropin

Abstract

Download Full-text

Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin

Thyroid ◽

10.1089/105072502320288438 ◽

2002 ◽

Vol 12 (7) ◽

pp. 583-590 ◽

Cited By ~ 60

Author(s):

Leonard Wartofsky

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Well Differentiated ◽

Recombinant Human Thyrotropin

Download Full-text

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79804-7 ◽

2010 ◽

Vol 2010 ◽

pp. 558-560

Author(s):

M. Schott ◽

S. Schinner

Keyword(s):

Thyroid Cancer ◽

Thyroid Hormone ◽

Cancer Patients ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Thyroid Hormone Withdrawal ◽

Radioiodine Ablation ◽

Recombinant Human Thyrotropin

Download Full-text

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2009-0869 ◽

2009 ◽

Vol 94 (11) ◽

pp. 4171-4179 ◽

Cited By ~ 57

Author(s):

R. Elisei ◽

M. Schlumberger ◽

A. Driedger ◽

C. Reiners ◽

R. T. Kloos ◽

...

Keyword(s):

Thyroid Cancer ◽

Thyroid Hormone ◽

Cancer Patients ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Thyroid Hormone Withdrawal ◽

Radioiodine Ablation ◽

Recombinant Human Thyrotropin

Download Full-text

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal

Yearbook of Endocrinology ◽

10.1016/s0084-3741(10)79440-3 ◽

2010 ◽

Vol 2010 ◽

pp. 169-171

Author(s):

M. Schott ◽

S. Schinner

Keyword(s):

Thyroid Cancer ◽

Thyroid Hormone ◽

Cancer Patients ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Thyroid Hormone Withdrawal ◽

Radioiodine Ablation ◽

Recombinant Human Thyrotropin

Download Full-text

Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of Jordan

Endocrine ◽

10.1007/s12020-021-02698-x ◽

2021 ◽

Author(s):

Malik E. Juweid ◽

Nidal J. Rabadi ◽

Mark Tulchinsky ◽

Mohammed Aloqaily ◽

Ahmad Al-Momani ◽

...

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Cancer Case ◽

American Thyroid Association ◽

Standard Practice ◽

Potential Impact ◽

Community Standard

Download Full-text

Letter Response to “Investigating the Sources of Heterogeneity in Systematic Review of Recurrence Rate after Hemi-Thyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer”

European Thyroid Journal ◽

10.1159/000513746 ◽

2021 ◽

Vol 10 (2) ◽

pp. 183-184

Author(s):

Samuel Chan ◽

Katarina Karamali ◽

Anna Kolodziejczyk ◽

Georgio Oikonomou ◽

John Watkinson ◽

...

Keyword(s):

Systematic Review ◽

Thyroid Cancer ◽

Recurrence Rate ◽

Differentiated Thyroid Cancer ◽

Low Risk ◽

Well Differentiated

Download Full-text

Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice

Journal of Endocrinological Investigation ◽

10.1007/bf03346652 ◽

2010 ◽

Vol 33 (8) ◽

pp. 579-586 ◽

Cited By ~ 3

Author(s):

E. Papini ◽

R. Negro ◽

A. Pinchera ◽

R. Guglielmi ◽

A. Baroli ◽

...

Keyword(s):

Thyroid Cancer ◽

Clinical Practice ◽

Thyroid Nodule ◽

Differentiated Thyroid Cancer ◽

Italian Association ◽

Cancer Management ◽

Joint Statement ◽

In Pregnancy

Download Full-text

In people with residual or metastatic differentiated thyroid cancer, what are the benefits and harms of recombinant human thyrotropin (rh TSH)-aided radioiodine treatment?

Cochrane Clinical Answers ◽

10.1002/cca.63 ◽

2014 ◽

Author(s):

Elie Mulhem

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Radioiodine Treatment ◽

Recombinant Human Thyrotropin

Download Full-text

PROGNOSTIC VALUE OF SERUM THYROGLOBULIN MEASURED AT 48 HOURS VERSUS 72 HOURS AFTER SECOND DOSE OF RECOMBINANT HUMAN THYROTROPIN IN SURVEILLANCE OF WELL-DIFFERENTIATED THYROID CANCER

Endocrine Practice ◽

10.1016/j.eprac.2020.09.002 ◽

2020 ◽

Author(s):

Shirin Haddady ◽

Emma Pinjic ◽

Stephanie L. Lee

Keyword(s):

Thyroid Cancer ◽

Prognostic Value ◽

Differentiated Thyroid Cancer ◽

Serum Thyroglobulin ◽

Well Differentiated ◽

Recombinant Human Thyrotropin

Download Full-text

Rare Cases of Differentiated Thyroid Cancer with Low-Risk Histology and Distant Metastases Have High Prevalence of RAS and TERT Mutations

Clinical Thyroidology ◽

10.1089/ct.2017;29.143-145 ◽

2017 ◽

Vol 29 (4) ◽

pp. 143-145

Author(s):

Masha J. Livhits ◽

Michael W. Yeh

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Distant Metastases ◽

Low Risk ◽

High Prevalence

Download Full-text